Sònia Sabate 4/1/26 Sònia Sabate 4/1/26 OrganoTherapeutics and CASK Luxembourg asbl launch an initiative to develop patient-derived brain organoid models for CASK, a rare neurological disorder (Copy) Read More Sònia Sabate 3/26/26 Sònia Sabate 3/26/26 Are Patient-Specific Midbrain Organoids Useful for Parkinson’s Drug Development? Read More Sònia Sabate 3/20/26 Sònia Sabate 3/20/26 Advancing Therapeutic Strategies for Neurodegenerative Diseases Read More Sònia Sabate 3/20/26 Sònia Sabate 3/20/26 OrganoTherapeutics February 2026 ; Data Integration in Human Brain Organoids Read More Sònia Sabate 1/30/26 Sònia Sabate 1/30/26 OrganoTherapeutics January 2026 ; Personalized medicine and organoid models Read More Sònia Sabate 1/30/26 Sònia Sabate 1/30/26 OrganoTherapeutics December 2025 ; Synapses and their detection in organoid models Read More Sònia Sabate 12/4/25 Sònia Sabate 12/4/25 OrganoTherapeutics Newsletter November 2025 ; First FDA IND Based Solely on Human Vascularized Organoid Data Read More Sònia Sabate 9/24/25 Sònia Sabate 9/24/25 OrganoTherapeutics Newsletter September 2025 ; Brain vasculature and midbrain-vascular assembloids. Read More Sònia Sabate 9/24/25 Sònia Sabate 9/24/25 OrganoTherapeutics Newsletter August 2025 ; FDA changes on Animal Alternatives in Research Read More Sònia Sabate 7/31/25 Sònia Sabate 7/31/25 Endogenous accumulation of alpha-synuclein in microglia-containing organoids; a new research breakthrough Read More Sònia Sabate 7/7/25 Sònia Sabate 7/7/25 OrganoTherapeutics Newsletter June 2025 ; Altered mtDNA dynamics and neurodegeneration in organoids Read More Sònia Sabate 7/1/25 Sònia Sabate 7/1/25 OrganoTherapeutics and molmir Announce Strategic Collaboration to Accelerate Neurodegenerative Disease Research Read More Sònia Sabate 6/30/25 Sònia Sabate 6/30/25 OrganoTherapeutics Newsletter - May 2025 ; Reproducibility of PD patient-specific midbrain organoid data Read More Sònia Sabate 4/24/25 Sònia Sabate 4/24/25 OrganoTherapeutics Joins Michael J. Fox Foundation’s LRRK2 Therapeutics Exchange with midbrain organoid systems Read More Sònia Sabate 4/23/25 Sònia Sabate 4/23/25 OrganoTherapeutics Newsletter - April 2025 ; Assessment and quantification of dopaminergic neurite fragmentation Read More Sònia Sabate 4/22/25 Sònia Sabate 4/22/25 Advancing reproducibility in organoid research: a breakthrough for midbrain models Read More Sònia Sabate 4/17/25 Sònia Sabate 4/17/25 FDA's shift from animal testing: unlocking the potential of midbrain organoids in drug development Read More Sònia Sabate 3/31/25 Sònia Sabate 3/31/25 OrganoTherapeutics Newsletter - March 2025 ; Neurofilament light release in organoids Read More Sònia Sabate 3/26/25 Sònia Sabate 3/26/25 OrganoTherapeutics Newsletter - February 2025 ; 3D tissue clearing for advanced imaging Read More Sònia Sabate 3/12/25 Sònia Sabate 3/12/25 Successful Project Collaboration with Animal Free Research UK: united for animal-free research Read More Older Posts
Sònia Sabate 4/1/26 Sònia Sabate 4/1/26 OrganoTherapeutics and CASK Luxembourg asbl launch an initiative to develop patient-derived brain organoid models for CASK, a rare neurological disorder (Copy) Read More
Sònia Sabate 3/26/26 Sònia Sabate 3/26/26 Are Patient-Specific Midbrain Organoids Useful for Parkinson’s Drug Development? Read More
Sònia Sabate 3/20/26 Sònia Sabate 3/20/26 Advancing Therapeutic Strategies for Neurodegenerative Diseases Read More
Sònia Sabate 3/20/26 Sònia Sabate 3/20/26 OrganoTherapeutics February 2026 ; Data Integration in Human Brain Organoids Read More
Sònia Sabate 1/30/26 Sònia Sabate 1/30/26 OrganoTherapeutics January 2026 ; Personalized medicine and organoid models Read More
Sònia Sabate 1/30/26 Sònia Sabate 1/30/26 OrganoTherapeutics December 2025 ; Synapses and their detection in organoid models Read More
Sònia Sabate 12/4/25 Sònia Sabate 12/4/25 OrganoTherapeutics Newsletter November 2025 ; First FDA IND Based Solely on Human Vascularized Organoid Data Read More
Sònia Sabate 9/24/25 Sònia Sabate 9/24/25 OrganoTherapeutics Newsletter September 2025 ; Brain vasculature and midbrain-vascular assembloids. Read More
Sònia Sabate 9/24/25 Sònia Sabate 9/24/25 OrganoTherapeutics Newsletter August 2025 ; FDA changes on Animal Alternatives in Research Read More
Sònia Sabate 7/31/25 Sònia Sabate 7/31/25 Endogenous accumulation of alpha-synuclein in microglia-containing organoids; a new research breakthrough Read More
Sònia Sabate 7/7/25 Sònia Sabate 7/7/25 OrganoTherapeutics Newsletter June 2025 ; Altered mtDNA dynamics and neurodegeneration in organoids Read More
Sònia Sabate 7/1/25 Sònia Sabate 7/1/25 OrganoTherapeutics and molmir Announce Strategic Collaboration to Accelerate Neurodegenerative Disease Research Read More
Sònia Sabate 6/30/25 Sònia Sabate 6/30/25 OrganoTherapeutics Newsletter - May 2025 ; Reproducibility of PD patient-specific midbrain organoid data Read More
Sònia Sabate 4/24/25 Sònia Sabate 4/24/25 OrganoTherapeutics Joins Michael J. Fox Foundation’s LRRK2 Therapeutics Exchange with midbrain organoid systems Read More
Sònia Sabate 4/23/25 Sònia Sabate 4/23/25 OrganoTherapeutics Newsletter - April 2025 ; Assessment and quantification of dopaminergic neurite fragmentation Read More
Sònia Sabate 4/22/25 Sònia Sabate 4/22/25 Advancing reproducibility in organoid research: a breakthrough for midbrain models Read More
Sònia Sabate 4/17/25 Sònia Sabate 4/17/25 FDA's shift from animal testing: unlocking the potential of midbrain organoids in drug development Read More
Sònia Sabate 3/31/25 Sònia Sabate 3/31/25 OrganoTherapeutics Newsletter - March 2025 ; Neurofilament light release in organoids Read More
Sònia Sabate 3/26/25 Sònia Sabate 3/26/25 OrganoTherapeutics Newsletter - February 2025 ; 3D tissue clearing for advanced imaging Read More
Sònia Sabate 3/12/25 Sònia Sabate 3/12/25 Successful Project Collaboration with Animal Free Research UK: united for animal-free research Read More
